Vital Signs - Managing Type 2 Diabetes: Risk vs. Reward

Vital Signs - Managing Type 2 Diabetes: Risk vs. Reward

 

RELEASE DATE
13-Aug-2007
REGION
North America
Research Code: 9561-00-3E-00-00
SKU: HC00494-NA-MR_03966
AvailableYesPDF Download
$1,500.00
In stock
SKU
HC00494-NA-MR_03966
$1,500.00
DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on August 13, 2007, provides a strategic overview of recent adverse risk issues impacting Avandia. Additionally, a company spotlight is provided for DiaKine Therapeutics, a developer of innovative therapies for diabetes and related complications. Reimbursement and regulatory news from the FDA is also provided for the week of July 30 - August 3, 2007.

Table of Contents

This week's issue:

Related Research
This issue of Vital Signs, released on August 13, 2007, provides a strategic overview of recent adverse risk issues impacting Avandia. Additionally, a company spotlight is provided for DiaKine Therapeutics, a developer of innovative therapies for diabetes and related complications. Reimbursement and regulatory news from the FDA is also provided for the week of July 30 - August 3, 2007.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-3E-00-00
Is Prebook No